Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study

Rikke Sørensen; Gunnar Gislason; Christian Tobias Torp-Pedersen; Jonas Bjerring Olesen; Emil L Fosbøl; Morten Hvidtfeldt; Deniz Karasoy; Morten Lamberts; Mette Charlot; Lars Køber; Peter Weeke; Gregory Y.H. Lip; Morten Lock Hansen

doi:10.1136/bmjopen-2013-002758

Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study

Rikke Sørensen, Gunnar Gislason, Christian Tobias Torp-Pedersen, Jonas Bjerring Olesen, Emil L Fosbøl, Morten Hvidtfeldt, Deniz Karasoy, Morten Lamberts, Mette Charlot, Lars Køber, Peter Weeke, Gregory Y.H. Lip, Morten Lock Hansen

Department of Cardiology

163 Citations (Scopus)

Abstract

Dabigatran was recently approved for anticoagulation in patients with atrial fibrillation (AF); data regarding real-world use, comparative effectiveness and safety are sparse.

Original language	English
Journal	BMJ Open
Volume	3
Issue number	5
ISSN	2044-6055
DOIs	https://doi.org/10.1136/bmjopen-2013-002758
Publication status	Published - 2013

Access to Document

10.1136/bmjopen-2013-002758Licence: CC BY-NC

Cite this

@article{858e67d8e6d9457c8ec0c8e23660670e,

title = "Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study",

abstract = "Dabigatran was recently approved for anticoagulation in patients with atrial fibrillation (AF); data regarding real-world use, comparative effectiveness and safety are sparse.",

author = "Rikke S{\o}rensen and Gunnar Gislason and Torp-Pedersen, \{Christian Tobias\} and Olesen, \{Jonas Bjerring\} and Fosb{\o}l, \{Emil L\} and Morten Hvidtfeldt and Deniz Karasoy and Morten Lamberts and Mette Charlot and Lars K{\o}ber and Peter Weeke and Lip, \{Gregory Y.H.\} and Hansen, \{Morten Lock\}",

year = "2013",

doi = "10.1136/bmjopen-2013-002758",

language = "English",

volume = "3",

journal = "BMJ Open",

issn = "2044-6055",

publisher = "BMJ Publishing Group Ltd",

number = "5",

}

TY - JOUR

T1 - Dabigatran use in Danish atrial fibrillation patients in 2011

T2 - a nationwide study

AU - Sørensen, Rikke

AU - Gislason, Gunnar

AU - Torp-Pedersen, Christian Tobias

AU - Olesen, Jonas Bjerring

AU - Fosbøl, Emil L

AU - Hvidtfeldt, Morten

AU - Karasoy, Deniz

AU - Lamberts, Morten

AU - Charlot, Mette

AU - Køber, Lars

AU - Weeke, Peter

AU - Lip, Gregory Y.H.

AU - Hansen, Morten Lock

PY - 2013

Y1 - 2013

N2 - Dabigatran was recently approved for anticoagulation in patients with atrial fibrillation (AF); data regarding real-world use, comparative effectiveness and safety are sparse.

AB - Dabigatran was recently approved for anticoagulation in patients with atrial fibrillation (AF); data regarding real-world use, comparative effectiveness and safety are sparse.

UR - https://www.scopus.com/pages/publications/84878451205

U2 - 10.1136/bmjopen-2013-002758

DO - 10.1136/bmjopen-2013-002758

M3 - Journal article

C2 - 23645926

SN - 2044-6055

VL - 3

JO - BMJ Open

JF - BMJ Open

IS - 5

ER -

Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study

Abstract

Access to Document

Other files and links

Fingerprint

Cite this